Fig. 3
The percentage of the onset time of haemorrhage reported in association with lenvatinib alone, pembrolizumab alone and combination therapy
Fig. 3 | BMC Pharmacology and Toxicology
The percentage of the onset time of haemorrhage reported in association with lenvatinib alone, pembrolizumab alone and combination therapy